Abiopharma

PainReform Ltd. (PRFX) Files Form 6-K

Ede-Golightly James 🟢 acquired 90.0K shares (1 derivative) of Silence Therapeutics plc (SLN) at $2.05 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Munch Mark 🟡 adjusted position in 33.8K shares (3 derivative) of BRUKER CORP (BRKR) at $50.00 ($3.2M) Transaction Date: Jan 05, 2026 | Filing ID: 000002

MCINERNEY TIMOTHY 🟢 acquired 90.0K shares (1 derivative) of Silence Therapeutics plc (SLN) at $2.05 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Romano Steven J. 🟢 acquired 300.0K shares (1 derivative) of Silence Therapeutics plc (SLN) at $2.05 Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001308 Size: 30 KB

ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference

Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference

New Form DEF 14A - Twist Bioscience Corp Filed: 2026-01-06 AccNo: 0001581280-26-000006 Size: 7 MB

New Form 424B5 - Praxis Precision Medicines, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001307 Size: 620 KB

New Form 3 - ELI LILLY & Co Filed: 2026-01-06 AccNo: 0001724605-26-000002 Size: 682 KB

Director Schenkein David P 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Director GOLDSTEIN JOSEPH L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002